Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004)
NCT06130332
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Oral Cancer
PD-1
Interventions
DRUG:
PD-1 with chemotherapy
PROCEDURE:
upright surgery
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University